1092P Nivolumab plus relatlimab vs nivolumab in previously untreated metastatic or unresectable melanoma: 3-year subgroup analyses from RELATIVITY-047

Autor: Schadendorf, D., Tawbi, H.A., Hodi, F.S., Lipson, E.J., Ascierto, P.A., Medina Soto, F.A., Maio, M., Hernberg, M., Mackiewicz, J., Prey, S., Mujika Eizmendi, M.K., Atkinson, V.G., Hassel, J.C., Cinat, G., Keidel, S., Rodriguez, S., Wang, P.T., Dolfi, S., Long, G.V.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S723-S724

Small molecules and targeted therapies in distant metastatic disease

Autor: Hersey, P. ^*, Bastholt, L., Chiarion-Sileni, V., Cinat, G., Dummer, R., Eggermont, A.M.M., Espinosa, E., Hauschild, A., Quirt, I., Robert, C., Schadendorf, D.

Publikováno v: In Annals of Oncology August 2009 20 Supplement 6:vi35-vi40

Results of EAHP's 2018 Survey on Medicines Shortages

Autor: Danzon, Patricia M., Kandolf Sekulovic, L., Guo, J., Agarwala, S., Hauschild, A., McArthur, G., Cinat, G., Wainstein, A., Caglevic, C., Lorigan, P., Gogas, H., Alvarez, M., Duncombe, R., Lebbe, C., Peris, K., Rutkowski, P., Stratigos, A., Forsea, A. M., De La Cruz Merino, L., Kukushkina, M., Dummer, R., Hoeller, C., Gorry, C., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Arenberger, P., Bylaite-Bucinskiene, M., Babovic, N., Banjin, M., Putnik, K., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Ymeri, A., Stojkovski, I., Garbe, C., Miljković, Nenad, Gibbons, Nicholas, Batista, Aida, Fitzpatrick, Raymond William, Underhill, Jonathan, Horák, Petr

Publikováno v: Danzon, P M, Kandolf Sekulovic, L, Guo, J, Agarwala, S, Hauschild, A, McArthur, G, Cinat, G, Wainstein, A, Caglevic, C, Lorigan, P, Gogas, H, Alvarez, M, Duncombe, R, Lebbe, C, Peris, K, Rutkowski, P, Stratigos, A, Forsea, A M, De La Cruz Merino, L, Kukushkina, M, Dummer, R, Hoeller, C, Gorry, C, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Arenberger, P, Bylaite-Bucinskiene, M, Babovic, N, Banjin, M, Putnik, K, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Ymeri, A, Stojkovski, I, Garbe, C, Miljković, N, Gibbons, N, Batista, A, Fitzpatrick, R W, Underhill, J & Horák, P 2019, ' Results of EAHP's 2018 Survey on Medicines Shortages ', European Journal of Hospital Pharmacy, pp. 60-65 . https://doi.org/10.1136/ejhpharm-2018-001835

Aims and objectives: \ud The aim of the 2018 EAHP Survey on Medicines Shortages was to provide a clearer picture on the issue of medicines shortages, including the impact on hospital pharmacists' time, budgets and the effect on patient care. Methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3efc7779c81526493df67f1225dc2b4b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1560PD - Major determinants of delayed access to innovative medicines for metastatic melanoma: The results of Melanoma World Society and European Association of Dermato-Oncology survey

Autor: Kandolf Sekulovic, L.O., Agarwala, S.S., Hauschild, A., Guo, J., McArthur, G.A., Lorigan, P., Cinat, G., Caglevich, C., Lebbe, C., Rutkowski, P.L., Gogas, H., Dummer, R., Neyns, B., Bastholt, L., Wainstein, A., Herceg, D., Banjin, M., Zhukavets, A., Ocvirk, J., Garbe, C.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8